Figure 1From: Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients Survival analysis for CD8-Res vs. CD8-NR to Her2. Survival analysis for the patients (n = 38) grouped according to CD8+ T cell response to Her2 (CD8-Res) and no CD8+ T cell response to Her2 (CD8-NR). Her2, human epidermal growth factor receptor 2.Back to article page